HeartFlow, a company that specializes in creating computerized heart models to treat coronary diseases, announced that its HeartFlow fractional flow reserved from CT (FFRct) Analysis will be covered ...
A chemotherapy drug used to fight bone-marrow cancer also has the potential to treat and prevent potentially deadly heart failure, a powerful new drug-screening tool developed at UVA Health suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback